MENU
KPTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Karyopharm Therapeutics (KPTI) Ownership - Who owns Karyopharm Therapeutics?
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.18M
P/E Ratio
N/A
Total Cash
69.94M
Projected Growth
N/A
Total Debt
186.7M
Revenue
142.13M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
8.10
Total Debt/Equity
N/A
Revenue/Share
16.44 USD as % of share price
Fundamentals
KPTI
Capitalization
40.2M
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
69.9M
Total Cash/Share
8.10
Total Debt
187M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
16.44%
Revenue
142M
ROE
N/A
Book Value
-205.88M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-7.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
1.33
Current Revenue Per Employee
107580.65
Dividends Per Share - Security
N/A
EBITDA
-19.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.67
Revenue To Assets
-37.64
Shares Held By Institutions
22.3M
Shares Outstanding - Current
8.64M
Total Liabilities
334M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-54.162
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com